Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.49 |
| ▸ | CA1 | P00915 | 4/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | XBP1 | P17861 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4612064 | 0.82 | CA2 (0.56) | CA2CA1MAPK1L3MBTL1GAA | |
| SCHEMBL4612488 | 0.81 | CA2 (0.50) | CA2CA1MAPK1L3MBTL1USP2 | |
| SCHEMBL4612475 | 0.80 | CA2 (0.46) | CA2CA1MAPK1L3MBTL1GAA | |
| SCHEMBL4609606 | 0.79 | CA2 (0.49) | CA2CA1MAPK1L3MBTL1GAA | |
| SCHEMBL4610618 | 0.78 | CA2 (0.47) | CA2CA1MAPK1L3MBTL1GAA | |
| SCHEMBL4611252 | 0.77 | CA2 (0.59) | CA2CA1MAPK1USP2FDPS | |
| SCHEMBL4609593 | 0.77 | CA2 (0.46) | CA2CA1MAPK1L3MBTL1USP2 | |
| SCHEMBL4612144 | 0.77 | CA2 (0.46) | CA2CA1MAPK1L3MBTL1ATM | |
| SCHEMBL4611198 | 0.76 | CYP3A4 (0.60) | CA2CA1MAPK1L3MBTL1ATM | |
| SCHEMBL4610648 | 0.73 | CA2 (0.42) | CA2CA1MAPK1L3MBTL1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1419182-B1 | IRON-BASED CATALYST COMPOSITION FOR THE MANUFACTURE OF SYNDIOTACTIC 1,2-POLYBUTADIENE | BRIDGESTONE CORP (JP) | 2008-10-15 | — | — | EP | disclosed |
| CN-1293102-C | Iron-based catalyst composition for producing syndiotactic 1, 2-polybutadiene | BRIDGESTONE CORP (JP) | 2007-01-03 | — | — | CN | disclosed |
| CN-1527844-A | Iron-based catalyst composition for the manufacture of syndiotactic 1.2-polybutadiene | ������������ʽ���� | 2004-09-08 | — | — | CN | disclosed |
| US-6610804-B2 | An iron compound, an alpha-acylphosphonate diester, and an organoaluminum compound | BRIDGESTONE CORPORATION (JP) | 2003-08-26 | — | — | US | disclosed |
| US-6576725-B1 | Iron compound, organomagnesium compound, and alpha-acylphosphonate diester; addition polymerization | BRIDGESTONE CORPORATION (JP) | 2003-06-10 | — | — | US | disclosed |
| US-20030073790-A1 | Iron-based catalyst composition for the manufacture of syndiotactic 1, 2-polybutadiene | BRIDGESTONE CORP. | 2003-04-17 | — | — | US | disclosed |
| US-20030073570-A1 | Method of preparing oligomers of conjugated dienes with an iron-based catalyst composition | BRIDGESTONE CORP. | 2003-04-17 | — | — | US | disclosed |